HDXY(SZ:002002)2023-10-30 16:00Financial Performance - The company's revenue for Q3 2023 was ¥270,748,291.44, representing a decrease of 78.30% compared to the same period last year[5]. - The net profit attributable to shareholders was a loss of ¥337,200,927.40, a decline of 4,193.67% year-on-year[5]. - The total profit for Q3 2023 was a loss of ¥884,863,773.28, representing a decrease of 366.64% compared to the previous year[10]. - The net profit for Q3 2023 was a loss of ¥819,525,378.53, a decline of 389.16% year-over-year[10]. - The basic and diluted earnings per share for Q3 2023 were both -¥0.2606, a decrease of 383.26% compared to the same period last year[10]. - The basic earnings per share for the period was -¥0.1080, a decrease of 4,253.85% compared to the same period last year[5]. - Operating profit for Q3 2023 was -876,273,261.40 CNY, down from 349,088,756.71 CNY in the same period last year[21]. - The company reported a total comprehensive income of -819,525,378.53 CNY for Q3 2023, compared to 283,414,391.48 CNY in Q3 2022[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥18,478,598,297.02, down 1.64% from the previous year-end[5]. - The company's total assets as of September 30, 2023, amounted to CNY 18,478,598,297.02, a slight decrease from CNY 18,786,559,429.36 at the beginning of the year[19]. - The company's total liabilities increased to CNY 8,976,590,820.59 from CNY 8,465,038,353.00, marking an increase of about 6.0%[19]. - The company’s total equity decreased to CNY 9,502,007,476.43 from CNY 10,321,521,076.36, reflecting a decline of about 7.9%[19]. Cash Flow - Cash flow from operating activities showed a net outflow of ¥4,267,118.21, a decrease of 94.37% year-on-year[5]. - Cash inflow from operating activities totaled ¥917,600,000.61, down 31.73% from ¥1,343,987,031.52 in the previous year[10]. - The net cash flow from operating activities was ¥4,267,118.21, a significant drop of 94.37% compared to ¥75,799,962.22 last year[10]. - The company’s cash and cash equivalents decreased to CNY 35,409,936.27 from CNY 44,947,804.38, a decline of about 21.2%[17]. - Cash and cash equivalents at the end of the period increased by 43.83% to ¥2,639,807.72 from ¥1,835,383.84[11]. - The company experienced a 270.45% increase in cash outflows from financing activities, totaling ¥14,286,799.15[11]. - The company did not obtain any new borrowings during the quarter, resulting in a 100% decrease in cash received from borrowings[11]. Expenses - The total operating income for the year-to-date was ¥2,219,816,266.08, down 42.04% from the previous year[9]. - The company reported a significant increase in management expenses, which rose by 195.44% due to provisions for losses during the shutdown of certain chlor-alkali facilities[9]. - Total operating costs for the third quarter of 2023 were CNY 3,060,095,655.57, down from CNY 3,430,755,085.94 year-on-year, indicating a reduction of about 10.8%[20]. - Research and development expenses for Q3 2023 were 47,941,762.66 CNY, slightly down from 49,891,815.68 CNY in Q3 2022[21]. - Financial expenses decreased to 184,712,051.19 CNY from 288,144,729.66 CNY year-over-year[21]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 154,539[13]. - The largest shareholder, Guangzhou Rural Commercial Bank, holds 10.92% of the shares, totaling 340,918,020 shares[13]. Operational Challenges - The company is actively working on the bankruptcy reorganization of its subsidiary, Inner Mongolia Wuhai Chemical Co., which has been under maintenance for over two months, impacting production significantly[15]. - The company experienced a 37.27% increase in accounts payable, totaling ¥1,052,067,825.12, indicating rising obligations[9]. - The company’s inventory as of September 30, 2023, was CNY 1,140,222,584.46, down from CNY 1,175,268,095.56 at the beginning of the year, indicating a decrease of approximately 3.0%[18]. Audit Status - The company has not undergone an audit for the Q3 2023 report[25].